These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serotonin inhibits apoptosis of pulmonary artery smooth muscle cell by pERK1/2 and PDK through 5-HT1B receptors and 5-HT transporters. Liu Y; Tian HY; Yan XL; Fan FL; Wang WP; Han JL; Zhang JB; Ma Q; Meng Y; Wei F Cardiovasc Pathol; 2013; 22(6):451-7. PubMed ID: 23601559 [TBL] [Abstract][Full Text] [Related]
4. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1. Liu Y; Fanburg BL Am J Respir Cell Mol Biol; 2006 Feb; 34(2):182-91. PubMed ID: 16195541 [TBL] [Abstract][Full Text] [Related]
5. RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling. Guilluy C; Eddahibi S; Agard C; Guignabert C; Izikki M; Tu L; Savale L; Humbert M; Fadel E; Adnot S; Loirand G; Pacaud P Am J Respir Crit Care Med; 2009 Jun; 179(12):1151-8. PubMed ID: 19299501 [TBL] [Abstract][Full Text] [Related]
6. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Marcos E; Fadel E; Sanchez O; Humbert M; Dartevelle P; Simonneau G; Hamon M; Adnot S; Eddahibi S Circ Res; 2004 May; 94(9):1263-70. PubMed ID: 15059929 [TBL] [Abstract][Full Text] [Related]
7. KMUP-1 inhibits pulmonary artery proliferation by targeting serotonin receptors/transporter and NO synthase, inactivating RhoA and suppressing AKT/ERK phosphorylation. Chung HH; Dai ZK; Wu BN; Yeh JL; Chai CY; Chu KS; Liu CP; Chen IJ Vascul Pharmacol; 2010; 53(5-6):239-49. PubMed ID: 20870034 [TBL] [Abstract][Full Text] [Related]
8. Serotonin transporter interacts with the PDGFβ receptor in PDGF-BB-induced signaling and mitogenesis in pulmonary artery smooth muscle cells. Ren W; Watts SW; Fanburg BL Am J Physiol Lung Cell Mol Physiol; 2011 Mar; 300(3):L486-97. PubMed ID: 21186266 [TBL] [Abstract][Full Text] [Related]
9. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis. Kappert K; Sparwel J; Sandin A; Seiler A; Siebolts U; Leppänen O; Rosenkranz S; Ostman A Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2644-51. PubMed ID: 16990553 [TBL] [Abstract][Full Text] [Related]
10. Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin. Liu Y; Suzuki YJ; Day RM; Fanburg BL Circ Res; 2004 Sep; 95(6):579-86. PubMed ID: 15297378 [TBL] [Abstract][Full Text] [Related]
11. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Eddahibi S; Fabre V; Boni C; Martres MP; Raffestin B; Hamon M; Adnot S Circ Res; 1999 Feb; 84(3):329-36. PubMed ID: 10024307 [TBL] [Abstract][Full Text] [Related]
12. Regulation of the platelet-derived growth factor receptor-beta by G protein-coupled receptor kinase-5 in vascular smooth muscle cells involves the phosphatase Shp2. Wu JH; Goswami R; Cai X; Exum ST; Huang X; Zhang L; Brian L; Premont RT; Peppel K; Freedman NJ J Biol Chem; 2006 Dec; 281(49):37758-72. PubMed ID: 17018529 [TBL] [Abstract][Full Text] [Related]
13. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation. Li B; Yang L; Shen J; Wang C; Jiang Z Anesth Analg; 2007 Oct; 105(4):1034-41, table of contents. PubMed ID: 17898384 [TBL] [Abstract][Full Text] [Related]
14. The serotonin pathway in pulmonary hypertension. Eddahibi S; Adnot S Arch Mal Coeur Vaiss; 2006 Jun; 99(6):621-5. PubMed ID: 16878724 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells. Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide. Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796 [TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species are required for 5-HT-induced transactivation of neuronal platelet-derived growth factor and TrkB receptors, but not for ERK1/2 activation. Kruk JS; Vasefi MS; Heikkila JJ; Beazely MA PLoS One; 2013; 8(9):e77027. PubMed ID: 24086766 [TBL] [Abstract][Full Text] [Related]